Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer.
Saved in:
| Title: | Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer. |
|---|---|
| Authors: | Peng C; Molecular Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Biology of Breast Cancer, Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany., Wallwiener M; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany., Rudolph A; Division of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ćuk K; Molecular Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Biology of Breast Cancer, Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany., Eilber U; Division of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Celik M; Division of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Modugno C; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany., Trumpp A; Hi-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine GmbH, Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Heil J; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany., Marmé F; Molecular Biology of Breast Cancer, Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany., Madhavan D; Molecular Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Biology of Breast Cancer, Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany., Nees J; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany., Riethdorf S; Department of Tumor Biology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Schott S; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany., Sohn C; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany., Pantel K; Department of Tumor Biology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Schneeweiss A; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany., Chang-Claude J; Division of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Yang R; Molecular Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Biology of Breast Cancer, Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany., Burwinkel B; Molecular Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Biology of Breast Cancer, Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. |
| Source: | International journal of cancer [Int J Cancer] 2016 May 15; Vol. 138 (10), pp. 2499-509. Date of Electronic Publication: 2016 Feb 16. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
